HEADER RNA BINDING PROTEIN 04-JUL-23 8POI TITLE MOLECULAR DOCKING OF SPF30 TUDOR DOMAIN WITH SYNTHETIC INHIBITOR 4- TITLE 2 (PYRIDIN-2-YL)THIAZOL-2-AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SURVIVAL OF MOTOR NEURON-RELATED-SPLICING FACTOR 30; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 30 KDA SPLICING FACTOR SMNRP,SMN-RELATED PROTEIN,SURVIVAL COMPND 5 MOTOR NEURON DOMAIN-CONTAINING PROTEIN 1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SMNDC1, SMNR, SPF30; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693 KEYWDS TUDOR DOMAIN, COMPLEX, INHIBITOR, RNA BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 4 AUTHOR J.BORGGRAEFE,S.GAUSSMANN,M.SATTLER REVDAT 2 30-AUG-23 8POI 1 JRNL REVDAT 1 23-AUG-23 8POI 0 JRNL AUTH L.ENDERS,M.SIKLOS,J.BORGGRAFE,S.GAUSSMANN,A.KOREN,M.MALIK, JRNL AUTH 2 T.TOMEK,M.SCHUSTER,J.REINIS,E.HAHN,A.RUKAVINA,A.REICHER, JRNL AUTH 3 T.CASTEELS,C.BOCK,G.E.WINTER,J.T.HANNICH,M.SATTLER,S.KUBICEK JRNL TITL PHARMACOLOGICAL PERTURBATION OF THE PHASE-SEPARATING PROTEIN JRNL TITL 2 SMNDC1. JRNL REF NAT COMMUN V. 14 4504 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 37587144 JRNL DOI 10.1038/S41467-023-40124-0 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : HADDOCK REMARK 3 AUTHORS : BONVIN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8POI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1292130327. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 70 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1 MM [U-13C; U-15N] SPF30(65 REMARK 210 -128), 20 MM NA- CMP13, 20 MM NA- REMARK 210 SODIUM PHOSPHATE, 50 MM NA- REMARK 210 NACL, 5 MM NA- DTT, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC REMARK 210 AROMATIC; 2D 1H-13C HSQC REMARK 210 ALIPHATIC; 3D HCCH-TOCSY; 2D REMARK 210 NOESY W1-13C-FILTERED; 2D NOESY REMARK 210 W2-13C-FILTERED; 3D NOESY W2-W1- REMARK 210 13C FILTERED REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CARA 1.9.1.7 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 400 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 4 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 3 SER A 66 -71.17 -129.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34831 RELATED DB: BMRB REMARK 900 MOLECULAR DOCKING OF SPF30 TUDOR DOMAIN WITH SYNTHETIC INHIBITOR 4- REMARK 900 (PYRIDIN-2-YL)THIAZOL-2-AMINE DBREF 8POI A 65 128 UNP O75940 SPF30_HUMAN 65 128 SEQRES 1 A 64 ALA SER THR GLN PRO THR HIS SER TRP LYS VAL GLY ASP SEQRES 2 A 64 LYS CYS MET ALA VAL TRP SER GLU ASP GLY GLN CYS TYR SEQRES 3 A 64 GLU ALA GLU ILE GLU GLU ILE ASP GLU GLU ASN GLY THR SEQRES 4 A 64 ALA ALA ILE THR PHE ALA GLY TYR GLY ASN ALA GLU VAL SEQRES 5 A 64 THR PRO LEU LEU ASN LEU LYS PRO VAL GLU GLU GLY HET ZTI A 201 19 HETNAM ZTI 4-PYRIDIN-2-YL-1,3-THIAZOL-2-AMINE FORMUL 2 ZTI C8 H7 N3 S SHEET 1 AA1 5 ALA A 114 PRO A 118 0 SHEET 2 AA1 5 THR A 103 PHE A 108 -1 N ILE A 106 O GLU A 115 SHEET 3 AA1 5 CYS A 89 ASP A 98 -1 N GLU A 95 O ALA A 105 SHEET 4 AA1 5 LYS A 78 VAL A 82 -1 N CYS A 79 O ALA A 92 SHEET 5 AA1 5 LYS A 123 PRO A 124 -1 O LYS A 123 N MET A 80 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1